Prev Arrow Stocks

Tilray Inc. ($TLRY) Stock Forecast: Down 5.1% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Tilray Inc.?

Tilray Brands (TLRY) is a Canadian cannabis company that has been experiencing a mix of challenges and opportunities in the market.

Why is Tilray Inc. going down?

TLRY stock is down 5.1% on Apr 1, 2026 18:25

  • Despite reporting record Q3 revenue of $206.7 million, Tilray's stock experienced a bearish movement due to concerns over a significant adjusted EPS miss, continuous shareholder dilution, and slow progress in U.S. cannabis rescheduling.
  • The surge in international cannabis sales by 73% sparked a rally in Tilray's shares, but the narrowed net loss that still missed consensus might have contributed to the overall bearish sentiment.
  • Anticipation of strong Q3 earnings, a new product launch, and decreased short interest led to a premarket surge in Tilray's stock, indicating short-term gains amidst a longer-term downtrend.
  • Investors are eagerly waiting for revenue growth to translate into sustainable profitability for Tilray, as the company navigates through challenges and opportunities in the cannabis market.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Sinks 4%: 3 Reasons the Market Isn’t Impressed Despite Record Q3 Revenue

Tilray Brands (TLRY) shares recently fell 4% despite reporting record Q3 revenue of $206.7 million, surpassing analyst estimates. The market's skepticism stems from a significant adjusted EPS miss ($0.24 loss vs. $0.14 expected), concerns over continuous shareholder dilution, and slow progress in U.S. cannabis rescheduling combined with an unproven beverage pivot. While the company showed improved net loss and reaffirmed EBITDA guidance, investors are waiting for revenue growth to translate into sustainable profitability.

https://247wallst.com/investing/2026/04/01/tilray-sinks-4-3-reasons-the-market-isnt-impressed-despite-record-q3-revenue/

0 News Article Image Tilray Sinks 4%: 3 Reasons the Market Isn’t Impressed Despite Record Q3 Revenue

Tilray's International Business Surge Sparks Rally — Retail Eyes ‘Upside Reversal’ After 30% Slide This Year

Tilray (TLRY) shares surged 4% after the company reported strong Q3 revenue, exceeding Wall Street estimates, primarily driven by a 73% increase in international cannabis sales. Despite a narrowed net loss that still missed consensus, the company reaffirmed its FY2026 EBITDA outlook and highlighted bullish prospects for its beverage segment's international expansion. Retail sentiment on Stocktwits shifted to "extremely bullish," with some anticipating an "upside reversal" after the stock's significant year-to-date decline.

https://stocktwits.com/news-articles/markets/equity/tlry-stock-q3-results-revenue-beat-retail-bullish-reversal/cZ7HVQlRIFb

1 Missing News Article Image Tilray's International Business Surge Sparks Rally — Retail Eyes ‘Upside Reversal’ After 30% Slide This Year

Tilray Brands posts record Q3 revenue $206.7M; gross profit $55.0M, adjusted EBITDA $10.7M

Tilray Brands announced record third fiscal quarter results for the period ending February 28, 2026, with net revenue of $206.7 million and a gross profit of $55.0 million. The company reported an improved net loss of $25.2 million and an adjusted net income of $2.4 million, with adjusted EBITDA reaching $10.7 million. Management reiterated its fiscal 2026 adjusted EBITDA guidance of $62 million to $72 million.

https://www.tradingview.com/news/tradingview:b5d2fcbfc8b1f:0-tilray-brands-posts-record-q3-revenue-206-7m-gross-profit-55-0m-adjusted-ebitda-10-7m/

2 News Article Image Tilray Brands posts record Q3 revenue $206.7M; gross profit $55.0M, adjusted EBITDA $10.7M

Why Tilray Brands Shares Are Surging In Wednesday's Premarket

Tilray Brands (NASDAQ: TLRY) shares are surging in premarket trading due to anticipation of strong Q3 fiscal 2026 earnings, a new product launch, and decreased short interest. The company has a history of beating EPS estimates and is introducing "High Voltage," a high-ABV beer. Despite short-term gains, the stock remains in a longer-term downtrend.

https://www.benzinga.com/trading-ideas/movers/26/04/51593480/why-tilray-brands-shares-are-surging-in-wednesdays-premarket

3 News Article Image Why Tilray Brands Shares Are Surging In Wednesday's Premarket

Tilray stock gains on Q3 revenue beat (TLRY:NASDAQ)

Tilray Brands (TLRY) saw its stock rise by approximately 3% in premarket trading after reporting better-than-expected revenue for Q3 fiscal 2026. The Canadian cannabis company's net revenue reached $206.7M, marking an ~11% year-over-year growth, primarily driven by its international operations.

https://seekingalpha.com/news/4571154-tilray-stock-gains-q3-revenue-beat

4 News Article Image Tilray stock gains on Q3 revenue beat (TLRY:NASDAQ)

Tilray Inc. Price History

10.02.2026 - TLRY Stock was up 6.9%

  • TLRY's bullish movement can be attributed to its strategic acquisition of BrewDog's Australian assets, including the Brisbane brewery and a network of bars, to expand its presence in the Asia-Pacific region.
  • The expansion into Australia serves as a gateway for Tilray to introduce its broader beverage portfolio to new markets, enhancing its global beverage revenues.
  • This move not only strengthens Tilray's international brewing footprint but also positions the company to capitalize on the growing demand for craft beverages in the Asia-Pacific market, driving investor optimism and contributing to the bullish market movement of TLRY.

01.03.2026 - TLRY Stock was down 5.1%

  • Despite reporting record Q3 revenue of $206.7 million, Tilray's stock experienced a bearish movement due to concerns over a significant adjusted EPS miss, continuous shareholder dilution, and slow progress in U.S. cannabis rescheduling.
  • The surge in international cannabis sales by 73% sparked a rally in Tilray's shares, but the narrowed net loss that still missed consensus might have contributed to the overall bearish sentiment.
  • Anticipation of strong Q3 earnings, a new product launch, and decreased short interest led to a premarket surge in Tilray's stock, indicating short-term gains amidst a longer-term downtrend.
  • Investors are eagerly waiting for revenue growth to translate into sustainable profitability for Tilray, as the company navigates through challenges and opportunities in the cannabis market.

24.01.2026 - TLRY Stock was up 5.3%

  • Despite a new exclusive licensing deal for beer distribution in the U.S. with Carlsberg, Tilray's stock continues to struggle, reflecting ongoing financial difficulties and consistent share price decline.
  • The company's active acquisition strategy and continual cash consumption have led to a decrease in shareholder value, prompting analysts to recommend exploring other investment options.
  • Despite a slight decrease in Tilray's stock value during a bullish market period, investors are eagerly awaiting the upcoming earnings report, hoping for positive growth in both earnings per share and revenue for the quarter.
  • The exclusive U.S. licensing agreement with Carlsberg aims to enhance Tilray's presence in the beverage market but market sentiment remains cautious due to the company's historical performance and limited growth prospects.

20.02.2026 - TLRY Stock was down 5.4%

  • Acquired BrewDog's US assets to expand alcohol beverage portfolio did not have a positive impact on stock price.
  • Despite expanding medical cannabis portfolio in Australia, introducing new products did not prevent bearish trend.
  • Underperformance compared to broader market and sector, along with anticipation of negative earnings per share in upcoming report, likely led to bearish movement.
  • Consecutive days of losses amidst challenging trading session for overall market emphasized bearish sentiment surrounding the stock.

19.01.2026 - TLRY Stock was up 5.8%

  • Tilray's stock experienced a strong bullish movement of over 4% following the announcement of the exclusive brewing and licensing agreement with Carlsberg Group.
  • The partnership with Carlsberg is expected to bring immediate scale and revenue to Tilray, driving optimism among investors and leading to the bullish market movement.
  • This strategic move aligns with Tilray's focus on partnering with established brands and maximizing its beverage operations, showcasing a promising future for the company in the competitive beer market.
  • The market's positive reaction reflects investor confidence in Tilray's ability to leverage its operational infrastructure effectively and strengthen its position in the premium European segment of the US beer market.

30.02.2026 - TLRY Stock was down 5.2%

  • Despite beating quarterly EPS and revenue estimates, Tilray's stock saw a significant dip, possibly due to concerns about the company's profitability and negative EPS forecasts for the current year.
  • The lawsuit filed by Bob Marley's heirs against Tilray for unpaid licensing fees may have added to investor uncertainty and contributed to the bearish movement of the stock.
  • The partnership announcement with Popsicle to launch new alcoholic beverages could have been overshadowed by the negative market sentiment, failing to provide a positive impact on the stock price.
  • Analysts' adjustments to price targets and earnings estimates, along with the overall market downturn, likely influenced investors to sell off Tilray shares, leading to the underperformance of the stock.

26.02.2026 - TLRY Stock was down 5.2%

  • Concerns arose among investors due to Tilray's partnership with Popsicle to launch "Popsicle Hard" beverages, potentially affecting its core business focus.
  • The anticipation of Tilray's third-quarter fiscal year 2026 financial results on April 1, 2026, could be causing uncertainty and volatility in the stock.
  • Investor caution regarding the financial results may lead to a sell-off of Tilray stock in expectation of disappointing earnings or guidance.
  • The absence of specific positive updates or catalysts may be contributing to the bearish sentiment surrounding Tilray's stock today.

25.02.2026 - TLRY Stock was up 6.6%

  • The increase in Tilray's stock price is likely the result of oversold conditions, leading to short-term optimism among investors.
  • Anticipation for the upcoming third fiscal quarter results scheduled for April 1, 2026, has contributed to positive market sentiment.
  • Despite facing profitability challenges with a negative net margin, recent company activities such as acquiring BrewDog U.S. assets and expanding medical cannabis partnerships have bolstered investor confidence.
  • Analyst opinions on the stock vary, with a consensus "Hold" rating; however, the temporary rebound suggests that investors are cautiously positive about Tilray's future prospects.

25.02.2026 - TLRY Stock was up 8.2%

  • TLRY stock rose by 3.57% to $6.68 today, following recent bearish trends, despite trading below significant moving averages.
  • The stock's uptick may be linked to oversold conditions identified by certain technical indicators, attracting short-term investors seeking opportunities.
  • Uncertainty over U.S. federal cannabis rescheduling discussions continues to impact investor sentiment, contributing to the stock's volatility.
  • TLRY's recent acquisition of craft brewer BrewDog and CEO Irwin Simon's plans to revitalize the brand through expansion efforts may have also influenced the positive market movement, highlighting the company's commitment to diversification and growth strategies.

05.02.2026 - TLRY Stock was down 5.2%

  • The purchase of BrewDog brand and assets may have sparked initial investor interest, but the subsequent stock decline suggests concerns over deal execution or financial impacts.
  • Despite expansions in product lines and partnerships, overall market sentiment and uncertainties about the upcoming earnings report likely contributed to TLRY's bearish movement.
  • Good Supply's introduction of high-THC products could have provided a small boost, but the limited availability and regional exclusivity may not have been enough to counter broader market pressures.
  • TLRY's stock outperformance in the last month despite sector challenges highlights investor scrutiny, particularly with the upcoming earnings report shaping market sentiments.

27.02.2026 - TLRY Stock was down 5.0%

  • Concerns arose among investors over Tilray's decision to enter the alcoholic ready-to-drink beverages market through a licensing agreement with The Magnum Ice Cream Company.
  • The upcoming quarterly earnings report, along with predictions of a potential EPS loss despite revenue growth from new beverage products, contributed to the negative market sentiment.
  • The general market downturn, as evidenced by declines in the NASDAQ Composite Index and the Dow Jones Industrial Average, influenced the selling pressure on Tilray stock.
  • Despite recent positive developments such as new partnerships and product launches, Tilray's stock struggled to surpass key moving averages, and conflicting analyst opinions may have fueled the downward trajectory.

31.02.2026 - TLRY Stock was up 5.3%

  • The launch of Shock Top's "High Voltage" beer with bold orange flavors and a 9.6% ABV has created market buzz. However, investor focus appears to be more on the company's financial standing.
  • Despite Tilray surpassing quarterly estimates, analysts have downgraded the stock to a "Hold" and reduced price targets, indicating concerns about profitability and financial well-being.
  • The forthcoming earnings report on April 1st will be a key factor in shaping the stock's future direction, with investors eager to see if Tilray's financial performance shows any signs of recovery.
  • Despite prevailing pessimism, the rise in institutional investors' holdings in the cannabis firm suggests enduring confidence in Tilray's growth prospects, potentially offering some stability to the stock in the short term.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.